Stemedica Cell Technologies reports that is has earned a new patent from the In its release on
The Company notes that the scaffolds are human skin equivalents that can be transplanted to regenerate skin in patients with skin defects, such as burn injuries, or diseases affecting skin, such as diabetic ulcers.
"Adding biologically active factors to Stemedica's original, patented cellular scaffolds might increase the engrafting capability and the potency of engrafted cells," says
Invented by Dr.
"Our newest patent is a significant achievement in tissue engineering, and it is another example of how Stemedica applies its expertise to push the boundary of what is possible with stem cells," says
Stemedica Cell Technologies is a specialty biopharmaceutical company.
More information and complete details:
((Comments on this story may be sent to email@example.com))
Stemedica Cell Technologies reports that is has earned a new patent from the
In its release on